Table 1.
Baseline Patient Characteristics
| Characteristic | Patients, No. (%) (N = 567) |
|---|---|
| Age, y | |
| 18–24 | 3 (0.5) |
| 25–34 | 41 (7.2) |
| 35–44 | 55 (9.7) |
| 45–54 | 206 (36.3) |
| 55–64 | 181 (31.9) |
| 65–74 | 71 (12.5) |
| ≥75 | 9 (1.6) |
| Male sex | 312 (55.0) |
| Institutional outpatient provider | 284 (50.1) |
| Treatment service | |
| Intensive care unit | 34 (6.0) |
| Internal medicine | 427 (75.3) |
| Surgery | 81 (14.3) |
| Obstetrics and gynecology | 16 (2.8) |
| Other (ENT, orthopedics) | 8 (1.4) |
| Multitablet home regimen | 353 (62.3) |
| Multitablet inpatient regimen | 458 (80.8) |
| Antiretroviral classa | |
| NNRTI | 106 (18.7) |
| PI | 118 (20.8) |
| INSTI | 438 (77.3) |
| NRTI-sparing | 25 (4.4) |
| CD4, cells/µL | |
| ≥200 | 453 (79.9) |
| 100–199 | 55 (9.7) |
| 50–99 | 22 (3.9) |
| <50 | 27 (4.8) |
| Unknown | 9 (1.6) |
Abbreviations: ENT, ear, nose, and throat; INSTI, integrase strand transfer inhibitor; NNRTI, nonnucleoside reverse-transcriptase inhibitor; NRTI, nucleoside reverse-transcriptase inhibitor; PI, protease inhibitor.
aSome patients received >1 class.